New Managing Director

Change in the management of the ipal company for patent exploitation mbH has been appointed Dr. Dirk Dantz (43) Berlin on October 1, 2010 to the new CEO of the ipal. The doctorate diploma mineralogist and European patent attorney has extensive experience in patent and technology management, as well as at home and Outlicensing in various management positions of major industrial enterprises. You may want to visit Professor of Internet Governance to increase your knowledge. Dr. Dirk Dantz replaces Haufe Ursula, who led the ipal GmbH since 2006.

I’m looking forward to my new responsibility of ipal GmbH”, says Dr. Dirk Dantz. The ipal turned up well in recent years as patent collecting society on the science site in Berlin. “” In this sense, I see it as my main task to continue this positive development continuously expand. “We thank Ursula Hakeem for the good cooperation and work for the company and wish her much success in their new duties in the lower Saxon Ministry of science and culture,” stresses Dr. Wilhelm Reiss, Chairman of the Supervisory Board of ipal GmbH. we are pleased to have won us Mr Dr. Dantz for this position and are convinced that with him the more design will succeed in the future of the ipal as successful patent collecting society.” About the ipal rated the ipal GmbH (innovations, patents, licences) and exclusively marketed the inventions of Berlin’s universities as patent Agency, and thus proposes an important bridge between science and industry. It is worn by the Freie Universitat Berlin (FU), the Humboldt University (HU), the Technical University (TU), the Hochschule fur Technik und Wirtschaft (HTW), Beuth Hochschule fur Technik (BHT) as well as the InvestitionsBank Berlin (IBB) as majority shareholder. From the assessment of patentable technologies through comprehensive patent protection up to the evaluation of the revenue potential in the market, the successful commercialization, as well as monitoring the royalties, the company provides all services. In addition the ipal GmbH with the cooperating Charite university medicine, the Robert-Koch-Institut, the German heart Centre, the Federal Institute for materials research and testing (BAM), with the Paul-Ehrlich-Institut Langen and the Jacobs University Bremen.